Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-G(D2) immunotherapy and isotretinoin

por Kushner, Brian H., Ostrovnaya, Irina, Cheung, Irene Y., Kuk, Deborah, Modak, Shakeel, Kramer, Kim, Roberts, Stephen S., Basu, Ellen M., Yataghene, Karima, Cheung, Nai-Kong V.
Publicado 2015

MYCN-amplified stage 2/3 neuroblastoma: excellent survival in the era of anti-G(D2) immunotherapy

por Kushner, Brian H., LaQuaglia, Michael P., Modak, Shakeel, Wolden, Suzanne L., Basu, Ellen M., Roberts, Stephen S., Kramer, Kim, Yataghene, Karima, Cheung, Irene Y., Cheung, Nai-Kong V
Publicado 2017